It was reported that daily intranasal administration of a novel PEI-conjugated R8-Aβ (25–35) peptide significantly reduced Aβ amyloid accumulation and ameliorated the memory deficits in PS-1/APP mice AD model [27]. The gene discussed is APP; the disease is Alzheimer disease.